Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$241K Hold
1,873
0.08% 68
2026
Q1
$225K Buy
+1,873
New +$216K 0.08% 63
2024
Q4
Sell
-1,873
Closed -$213K 75
2024
Q3
$213K Hold
1,873
0.12% 60
2024
Q2
$232K Hold
1,873
0.13% 53
2024
Q1
$247K Hold
1,873
0.15% 51
2023
Q4
$204K Buy
+1,873
New +$194K 0.15% 53
2023
Q3
Sell
-1,873
Closed -$216K 56
2023
Q2
$216K Buy
+1,873
New +$213K 0.2% 52
2023
Q1
Sell
-1,873
Closed -$208K 174
2022
Q4
$208K Hold
1,873
0.18% 43
2022
Q3
$161K Hold
1,873
0.11% 53
2022
Q2
$171K Hold
1,873
0.1% 56
2022
Q1
$154K Hold
1,873
0.09% 65
2021
Q4
$144K Buy
+1,873
New +$149K 0.09% 78

Other funds holding MRK

Seldon Capital's MRK Position: Q2 2026 in Review

Seldon Capital held its Merck (MRK) position steady in Q2 2026 at 1,873 shares worth $241K. The position accounts for 0.08% of the portfolio, ranked #68.

Seldon Capital first reported a position in MRK in Q4 2021 and has held it in 12 quarters since. The position peaked at $247K in Q1 2024. 3,833 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Seldon Capital held 1,873 shares of Merck worth $241K as of Q2 2026.
  • Seldon Capital left its Merck share count unchanged in Q2 2026.
  • Merck made up 0.08% of Seldon Capital's portfolio in Q2 2026, its #68 holding.
  • Seldon Capital first reported a position in Merck in Q4 2021 and has held it in 12 quarters since.
  • Seldon Capital's Merck position peaked at $247K in Q1 2024.
  • 3,833 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Seldon Capital's 13F filing for Q2 2026, filed 14 Aug 2026.